ArticleFrontiers in oncology2022

Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approach.

Alessandra Fabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.